Jacobson M A, O'Donnell J J, Rousell R, Dionian B, Mills J
Medical Service, San Francisco General Hospital, California 94110.
Antimicrob Agents Chemother. 1990 Jan;34(1):176-8. doi: 10.1128/AAC.34.1.176.
Six men with acquired immunodeficiency syndrome (AIDS) and cytomegalovirus (CMV) retinitis, treated with combined ganciclovir induction therapy and hyperimmune globulin (CMV-IGIV) for 10 days followed by CMV-IGIV alone, had a median time to retinitis progression shorter (7 days) than had eight historical controls given ganciclovir maintenance therapy (54 days; P = 0.06) and similar to that in eight controls given ganciclovir for 10 days only (19 days; P = 0.97). CMV-IGIV, which also failed to inhibit CMV replication in blood and urine, did not appear to add markedly to the efficacy of ganciclovir in acquired immunodeficiency syndrome-associated CMV retinitis.
六名患有获得性免疫缺陷综合征(AIDS)和巨细胞病毒(CMV)视网膜炎的男性,接受了更昔洛韦诱导联合治疗和高免疫球蛋白(CMV-IGIV)治疗10天,随后仅接受CMV-IGIV治疗,其视网膜炎进展的中位时间(7天)比八名接受更昔洛韦维持治疗的历史对照患者(54天;P = 0.06)短,且与八名仅接受更昔洛韦治疗10天的对照患者(19天;P = 0.97)相似。CMV-IGIV在血液和尿液中也未能抑制CMV复制,在获得性免疫缺陷综合征相关的CMV视网膜炎中,它似乎并未显著增加更昔洛韦的疗效。